Special Issue "Marine Actinomycetes: A New Source of Natural Products"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 December 2009)

Special Issue Editor

Guest Editor
Prof. Dr. Jose A. Salas
Department of Functional Biology (Area Microbiology), Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain
Website: http://www.unioviedo.es/IUOPA/index.php?option=com_content&view=article&id=69:biosintesis-de-moleculas-antitumorales&Itemid=125&lang=en
E-Mail: jasalas@uniovi.es
Phone: +34 985 103652
Fax: +34 985 103652
Interests: bioactive natural products; anticancer agents; antimicrobial agents; biosynthesis

Special Issue Information

Dear Colleagues,

Actinomycetes are filamentous Gram-positive bacteria with a complex life cycle which are widely distributed in terrestrial ecosystems, especially in soil. They are producers of a large number of natural products, many of them with clinical, pharmaceutical or agricultural application. In the last decades, marine actinomycetes are increasingly being isolated from marine environments demonstrating that actinomycetes are ubiquitous in marine sediments, but at lower numbers than in soils. Furthermore, marine actinomycetes have been found in symbiosis with different marine invertebrates, especially sponges. They have attracted great attention since they have developed unique metabolic and physiological capabilities that offer the potential to produce natural products with interesting pharmacological activities and therefore they provide a source of novel natural products with potential application in the near future.

Prof. Dr. Jose A. Salas
Guest Editor

Keywords

  • non-ribosomal peptides
  • polyketides
  • Streptomyces
  • Micromonospora
  • secondary metabolites
  • bioactive compounds

Published Papers (2 papers)

Mar. Drugs 2010, 8(3), 399-412; doi:10.3390/md8030399
Received: 29 December 2009; in revised form: 3 February 2010 / Accepted: 5 February 2010 / Published: 26 February 2010
Show/Hide Abstract | Cited by 35 | PDF Full-text (273 KB) | HTML Full-text | XML Full-text | Supplementary Files

Mar. Drugs 2009, 7(4), 483-494; doi:10.3390/md7040483
Received: 26 August 2009; in revised form: 14 October 2009 / Accepted: 19 October 2009 / Published: 19 October 2009
Show/Hide Abstract | Cited by 5 | PDF Full-text (289 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 27 February 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert